Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)

Allogeneic hematopoietic cell transplantation (HCT) from human leukocyte antigen (HLA) matched related donor (MRD) and matched unrelated donors (MUD) produces similar survival for patients with acute myelogenous leukemia. Whether these results can be extended to patients with myelodysplastic syndrom...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Saber, Wael, Cutler, Corey S., Nakamura, Ryotaro, Zhang, Mei-Jie, Atallah, Ehab, Rizzo, J. Douglas, Maziarz, Richard T., Cortes, Jorge, Kalaycio, Matt E., Horowitz, Mary M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2013
Matèries:
Transplantation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3772501/
https://ncbi.nlm.nih.gov/pubmed/23847196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-04-496778
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars